Works matching AU Knoblauch, Roland

Results: 8

Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Published in:

2019

By:

Patel, Shreyaskumar;
von Mehren, Margaret;
Reed, Damon R.;
Kaiser, Pamela;
Charlson, John;
Ryan, Christopher W.;
Rushing, Daniel;
Livingston, Michael;
Singh, Arun;
Seth, Rahul;
Forscher, Charles;
D'Amato, Gina;
Chawla, Sant P.;
McCarthy, Sharon;
Wang, George;
Parekh, Trilok;
Knoblauch, Roland;
Hensley, Martee L.;
Maki, Robert G.;
Demetri, George D.

Publication type:

journal article

Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1047, doi. 10.1007/s00280-015-2705-z

By:

Mehren, Margaret;
Bookman, Michael;
Meropol, Neal;
Weiner, Louis;
Sherman, Eric;
Li, Jinhui;
Knoblauch, Roland;
Parekh, Trilok;
Cohen, Roger

Publication type:

Article

Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 729, doi. 10.1007/s00280-014-2554-1

By:

Machiels, Jean-Pascal;
Staddon, Arthur;
Herremans, Catherine;
Keung, Chi;
Bernard, Apexa;
Phelps, Charles;
Khokhar, Nushmia;
Knoblauch, Roland;
Parekh, Trilok;
Dirix, Luc;
Sharma, Sunil

Publication type:

Article

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Published in:

2019

By:

Jones, Robin L.;
Maki, Robert G.;
Patel, Shreyaskumar R.;
Wang, George;
McGowan, Tracy A.;
Shalaby, Waleed S.;
Knoblauch, Roland E.;
von Mehren, Margaret;
Demetri, George D.

Publication type:

journal article

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.

Published in:

Cancer Medicine, 2021, v. 10, n. 11, p. 3565, doi. 10.1002/cam4.3903

By:

Jones, Robin L.;
Herzog, Thomas J.;
Patel, Shreyaskumar R.;
von Mehren, Margaret;
Schuetze, Scott M.;
Van Tine, Brian A.;
Coleman, Robert L.;
Knoblauch, Roland;
Triantos, Spyros;
Hu, Peter;
Shalaby, Waleed;
McGowan, Tracy;
Monk, Bradley J.;
Demetri, George D.

Publication type:

Article

Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.

Published in:

Investigational New Drugs, 2018, v. 36, n. 3, p. 476, doi. 10.1007/s10637-017-0546-9

By:

Calvo, Emiliano;
Azaro, Analia;
Rodon, Jordi;
Dirix, Luc;
Huizing, Manon;
Senecal, Francis Mark;
LoRusso, Patricia;
Yee, Lorrin;
Poggesi, Italo;
de Jong, Jan;
Triantos, Spyros;
Park, Youn C.;
Knoblauch, Roland E.;
Parekh, Trilok V.;
Demetri, George D.;
von Mehren, Margaret

Publication type:

Article

Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 468, doi. 10.1002/cpt.3064

By:

Haddish‐Berhane, Nahor;
Su, Yaming;
Russu, Alberto;
Thayu, Meena;
Knoblauch, Roland E.;
Mehta, Jaydeep;
Xie, John;
Gibbs, Eric;
Sun, Yu‐Nien;
Zhou, Honghui

Publication type:

Article

Toxicity of argatroban overdose in a 65-year-old man.

Published in:

American Journal of Hematology, 2005, v. 79, n. 3, p. 248, doi. 10.1002/ajh.20335

By:

Roland Knoblauch;
Eleanor S. Pollak;
J. Eric Russell

Publication type:

Article